Literature DB >> 11372392

[Study on family aggregation of esophageal cancer in Linzhou city].

Q Shi1, D Xu, C Sun.   

Abstract

OBJECTIVE: To investigate family aggregation of esophageal cancer (EC) in Linzhou city, a high risk area for EC.
METHODS: A hospital based case-control study were conducted, which included relatives of 118 EC cases and 168 controls. EC incidences in relatives of cases and controls were compared by chi 2 test and risk ratio (RR) was calculated. Heritability (h2) was estimated using the Falconer method.
RESULTS: EC incidence of case relatives was significantly higher than that in control relatives. The RR was 3.15 (2.15-4.61) in the first degree relatives and 1.87 (1.26-2.79) in the second degree relatives. The heritability was (53.39 +/- 5.93)% for the first degree relatives and (50.21 +/- 10.75)% for the second degree relatives, while the weighted h2 was (52.26 +/- 3.82)%.
CONCLUSION: The genetic factor plays an important role the occurrence of EC in Linzhou city; however, environmental factors should not be ignored.

Entities:  

Mesh:

Year:  2000        PMID: 11372392

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  3 in total

1.  Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an.

Authors:  An-Hui Wang; Chang-Sheng Sun; Liang-Shou Li; Jiu-Yi Huang; Qing-Shu Chen
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Genetic susceptibility and environmental factors of esophageal cancer in Xi'an.

Authors:  An-Hui Wang; Chang-Sheng Sun; Liang-Shou Li; Jiu-Yi Huang; Qing-Shu Chen; De-Zhong Xu
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer.

Authors:  Zhiwei Chang; Weijie Zhang; Zhijun Chang; Min Song; Yanru Qin; Fubao Chang; Haiyun Guo; Qingli Wei
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.